AzTrials
AzTrials

Postpartum HemorrhageNCT07884890

Measured Versus Hemoglobin-Calculated Postpartum Blood Loss in Waterbirth

An observational study of Postpartum Hemorrhage and Waterbirth, run by University of Campania Luigi Vanvitelli at 2 sites in Italy.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

During a waterbirth, blood lost in the pool between the birth of the baby and the mother's exit from the water cannot be collected or measured. At the participating centers, blood loss is measured with a graduated collector bag that is positioned only after the woman leaves the pool, for the delivery of the placenta. Read more about this study

Who is it for?
Ages 18 to 50 years, women only
Conditions the study is for
Postpartum Hemorrhage, Waterbirth
What is being tested?
Water immersion during labor and birth
How many people
600 participants
Where
2 sitesItaly
Study dates
Apr 2027to Oct 2029
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: Low-risk women with a singleton pregnancy at term giving birth at two Italian maternity units (Caserta and Avellino) that offer water immersion in labor and waterbirth. Women are identified consecutively from the delivery ward register and classified according to their actual use of water immersion.

Who may be able to join

  • Singleton pregnancy
  • Cephalic presentation
  • Gestational age from 37 weeks 0 days to 41 weeks 6 days
  • Low-risk pregnancy, eligible for water immersion according to the protocol of the center
  • Hemoglobin measured at admission in labor
  • Vaginal birth; for Group C, spontaneous vaginal birth with no water immersion at any time in labor

Who cannot join

  • Blood transfusion before the postpartum blood sample
  • Known coagulopathy
  • Cesarean delivery
  • Operative vaginal delivery (Group C)

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Italy2 sites
  • Azienda Ospedaliera San Giuseppe Moscati - UOC di Ginecologia e Ostetricia

    Avellino, Campania

  • University of Campania Luigi Vanvitelli

    Caserta, Campania

Other trials in Italy

About this study

Official title: Measured Versus Hemoglobin-Calculated Postpartum Blood Loss After Waterbirth Compared With Land Birth: A Multicenter Observational Cohort Study

During a waterbirth, blood lost in the pool between the birth of the baby and the mother's exit from the water cannot be collected or measured. At the participating centers, blood loss is measured with a graduated collector bag that is positioned only after the woman leaves the pool, for the delivery of the placenta. The blood loss recorded after a waterbirth may therefore be lower than the true loss. The goal of this observational study, conducted in two Italian hospitals, is to learn whether measured blood loss underestimates true blood loss more after waterbirth than after birth on land. The main question it aims to answer is: Is the difference between blood loss calculated from the drop in hemoglobin and blood loss measured in the collector bag larger in women who give birth in water than in women who give birth on land without water immersion? Researchers will compare three groups of low-risk women with a singleton pregnancy at term: women who give birth in water, women who use water immersion during labor but give birth out of water, and women who do not use water immersion. No intervention is assigned by the study: each woman is classified according to what actually happened during her labor and birth. Data are taken from the clinical record and include hemoglobin at admission in labor and after birth, measured blood loss, and the timing of events in the pool and during the third stage of labor.

Read the detailed description

Design: multicenter observational cohort study conducted in two centers in Italy (Caserta and Avellino), with consecutive inclusion over 24 months. Exposure groups are defined by what actually occurred: Group A, birth in water; Group B, water immersion during labor with birth out of water (the reason for leaving the pool is recorded); Group C, no water immersion and spontaneous vaginal birth on land. All consecutive Group A and Group B births in the study period are included. Group C is formed from the delivery ward register of the same center: for each waterbirth (index case), the next three consecutive eligible births of the same parity category (nulliparous or parous) occurring within 30 days are selected; each woman can serve as a control only once, and every woman screened and skipped is logged with the reason. Eligibility of controls is decided on admission data, without knowledge of outcomes. A control with missing data is not replaced. Epidural analgesia is not an exclusion criterion; it is recorded and the analysis is repeated without those women. Blood loss assessment: measured blood loss is the volume collected in a graduated collector bag. After waterbirth the bag is positioned after the woman leaves the pool, for the delivery of the placenta. Calculated blood loss = estimated blood volume x (pre-delivery hemoglobin - postpartum hemoglobin) / pre-delivery hemoglobin, where estimated blood volume (mL) = maternal weight (kg) x 85. Pre-delivery hemoglobin is measured at admission in labor; postpartum hemoglobin is targeted at 48 hours after birth (accepted window 36 to 60 hours), at the same interval in all groups. Primary analysis: comparison between Group A and Group C of the individual difference between calculated and measured blood loss, adjusted for center, maternal age, parity, body mass index, gestational age, onset of labor, oxytocin use, duration of the first and second stage, birth weight, intravenous fluids between the two blood samples, iron therapy in pregnancy, and hours between birth and the postpartum sample. Mechanism analysis: in Group A, the difference between calculated and measured blood loss is modeled as a function of the minutes between birth and positioning of the collector bag; minutes spent in the pool after birth are used in a sensitivity analysis. A further sensitivity analysis is restricted to women sampled between 36 and 60 hours after birth. Sample size: anticipated total enrollment of 600 women over 24 months across the two centers, with three Group C controls for each Group A waterbirth; all eligible women in Group B are included. The standard deviation of the primary outcome will be re-estimated on the first 100 cases, pooled across groups and without examining the between-group difference, and the sample size updated accordingly. Prespecified secondary analyses on the same cohort: duration and management of the third stage of labor after waterbirth versus land birth; influence of postpartum sampling time and intravenous fluids on calculated blood loss; association between duration of water immersion and postpartum hemoglobin drop; reasons for leaving the pool before birth and related outcomes; perineal trauma by parity. Neonatal and infectious outcomes are reported descriptively only, because the study is not powered for rare events.

Being tested
Water immersion during labor and birth
Keywords
water immersion, calculated blood loss, quantitative blood loss, third stage of labor
Medical subject headings
Postpartum Hemorrhage

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Water immersion during labor and birthOther

    Exposure of interest, not assigned by the study. Women choose whether to use the birthing pool as part of routine care: immersion in warm water during labor only (Group B) or during labor and birth of the baby (Group A). The study only observes and records the exposure and its timing.

Study groups in NCT07884890
Study groupRoleWhat they receive
Group A: WaterbirthWomen who gave birth in water. All consecutive waterbirths in the study period are included. The graduated collector bag is positioned after the woman leaves the pool, for the delivery of the placenta. No intervention is assigned by the study.
Receives: Other: Water immersion during labor and birth
Group B: Water Immersion in Labor, Birth out of WaterWomen who used water immersion during labor and gave birth out of water. All consecutive women in the study period are included, and the reason for leaving the pool is recorded. No intervention is assigned by the study.
Receives: Other: Water immersion during labor and birth
Group C: Land Birth Without Water ImmersionWomen with no water immersion at any time in labor and a spontaneous vaginal birth on land. For each waterbirth, the next three consecutive eligible births of the same parity category within 30 days are selected from the delivery ward register. No intervention is assigned by the study.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference between calculated and measured blood loss

    Individual difference, in mL, between calculated blood loss and blood loss measured in the graduated collector bag. Calculated blood loss = maternal weight (kg) x 85 x (hemoglobin at admission in labor - postpartum hemoglobin) / hemoglobin at admission in labor. The difference is compared between Group A (waterbirth) and Group C (land birth without water immersion).

    Measured: From admission in labor to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours)

Secondary outcomes (6)
  1. Peripartum hemoglobin drop

    Hemoglobin at admission in labor minus postpartum hemoglobin, in g/dL, compared between groups. The proportion of women with a drop of 2 g/dL or more is also reported.

    Measured: From admission in labor to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours)

  2. Postpartum hemorrhage of 500 mL or more, by each assessment method

    Proportion of women with blood loss of 500 mL or more, reported separately for blood loss measured in the collector bag and for calculated blood loss, and compared between groups.

    Measured: From birth to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours)

  3. Postpartum hemorrhage of 1000 mL or more, by each assessment method

    Proportion of women with blood loss of 1000 mL or more, reported separately for blood loss measured in the collector bag and for calculated blood loss, and compared between groups.

    Measured: From birth to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours)

  4. Red blood cell transfusion

    Proportion of women receiving a red blood cell transfusion after birth, and number of units transfused, compared between groups.

    Measured: From birth to hospital discharge, an average of 3 days

  5. Intravenous iron administration

    Proportion of women receiving intravenous iron after birth, compared between groups.

    Measured: From birth to hospital discharge, an average of 3 days

  6. Duration of the third stage of labor

    Minutes between birth of the baby and delivery of the placenta, compared between Group A and Group C.

    Measured: From birth of the baby to delivery of the placenta, up to 2 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Oct 2026
  2. Study startApr 2027 (estimated)
  3. Primary completionApr 2029 (estimated)
  4. Study completionOct 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
600 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07884890
Sponsor's protocol ID
WB-BLOODLOSS-2026
Status last verified
Oct 2026
First submitted
13 Oct 2026
Last updated
21 Oct 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data will not be shared due to institutional policies and the protection of participants' privacy.

Questions about this trial

What is this clinical trial studying?

An observational study of Postpartum Hemorrhage and Waterbirth, run by University of Campania Luigi Vanvitelli at 2 sites in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 21 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Marco La Verde, MD (+390815665600, marco.laverde@unicampania.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference between calculated and measured blood loss (time frame: From admission in labor to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in